PharmaSGP Holding SE

Company Description

---

harmaSGP is a pharmaceutical company with a broad portfolio of leading, over-the-counter (OTC) drugs and other healthcare products.

Our drugs are based on natural pharmaceutical active ingredients with documented efficacy and have virtually no known side effects. With our pharmacy-exclusive products, we have trusted brands in many relevant chronic indications that are leaders in their respective categories. The herbal-medicine Baldriparan®, is the leading OTC brand in Germany for natural valerian sleep aids. With the brands RubaXX® for rheumatic pain and Restaxil® for neuralgic pain (nerve pain), we are also the market leader for systemic, chemical-free OTC pain relievers.

In addition, the products against sexual weakness, which are marketed under the brands DESEO® and NERADIN®, are the leading chemical-free products in their category in Germany.

Since the launch of the first product from the current portfolio in Germany in 2012, we have successfully exported our business.

Year founded

---

2019

Served area

---

Worldwide

Headcount

---

66

Headquarters

---

Lochhamer Schlag 21, 82166 Gräfelfing – Germany

Shares outstanding

---

12,000,000

IPO

---

June 19, 2020

Designated Sponsor(s)

---

Joh. Berenberg, Gossler & Co. KG

Stock exchange(s)

---

Frankfurt Stock Exchange